Evidence map›Paper›PMID 39173814›Full record

ArticleDevelopmental biology2024

The Caenorhabditis elegans protein SOC-3 permits an alternative mode of signal transduction by the EGL-15 FGF receptor.

Claudia S Rodriguez Torres, Nicole B Wicker, Victória Puccini de Castro, Mariya Stefinko, Daniel C Bennett, Brooke Bernhardt, Melissa Garcia Montes de Oca, Sainabou Jallow, Katelyn Flitcroft, Jessica-Jae S Palalay and 8 more

Abstract read
In one paragraph

Article in Developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Claudia S Rodriguez TorresDepartment of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, 53201, USA.
Nicole B WickerDepartment of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, 53201, USA.
Victória Puccini de CastroDepartment of Biology, Northeastern Illinois University, Chicago, IL, 60625, USA.
Mariya StefinkoDepartment of Biology, Northeastern Illinois University, Chicago, IL, 60625, USA.
Daniel C BennettYale University School of Medicine, New Haven, CT, 06520, USA.
Brooke BernhardtDepartment of Biology, Ithaca College, Ithaca, NY, 14850, USA.
Melissa Garcia Montes de OcaDepartment of Biology, Northeastern Illinois University, Chicago, IL, 60625, USA.
Sainabou JallowDepartment of Biology, Ithaca College, Ithaca, NY, 14850, USA.
Katelyn FlitcroftDepartment of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, 53201, USA.
Jessica-Jae S PalalayDepartment of Biology, Northeastern Illinois University, Chicago, IL, 60625, USA.
Omar A Payán ParraDepartment of Biology, Northeastern Illinois University, Chicago, IL, 60625, USA.
Yaakov E SternDepartment of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA.
Michael R KoelleYale University School of Medicine, New Haven, CT, 06520, USA.
Cindy VoisineDepartment of Biology, Northeastern Illinois University, Chicago, IL, 60625, USA.
Ian G WoodsDepartment of Biology, Ithaca College, Ithaca, NY, 14850, USA.
Te-Wen LoDepartment of Biology, Ithaca College, Ithaca, NY, 14850, USA.
Michael J SternDepartment of Biology, Northeastern Illinois University, Chicago, IL, 60625, USA.
Claire C de la CovaDepartment of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, 53201, USA. Electronic address: delacova@uwm.edu.

Funding

Research Education CoreU54CA202997 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PETERSON, CARYN E., PETERSON, CARYN E. · 2015 to 2024
$13.8M
Research Education CoreU54CA203000 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI YANEZ, BETINA · 2015 to 2024
$12.4M
The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)U54CA202995 · NCI · NORTHEASTERN ILLINOIS UNIVERSITY · PI KAHOUADJI, NABIL · 2015 to 2024
$9.5M
Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Signaling Specificity Mediated by the C. elegans FGF Receptor Tyrosine KinaseR15GM122001 · NIGMS · ITHACA COLLEGE · PI LO, TE-WEN · 2017 to 2017
$345k
Mechanisms of protein degradation that control signal transduction by Ras-Raf-MEK-ERKR03CA248684 · NCI · UNIVERSITY OF WISCONSIN MILWAUKEE · PI DE LA COVA, CLAIRE · 2021 to 2022
$152k
NCI NIH HHS R03 CA248684NCI NIH HHS U54 CA202995NCI NIH HHS U54 CA202997NCI NIH HHS U54 CA203000NIGMS NIH HHS P41 GM103311NIGMS NIH HHS R15 GM122001NIH HHS P40 OD010440
6 · The paper itself

Abstract

Fibroblast Growth Factors and their receptors (FGFRs) comprise a cell signaling module that can stimulate signaling by Ras and the kinases Raf, MEK, and ERK to regulate animal development and homeostatic functions. In Caenorhabditis elegans, the sole FGFR ortholog EGL-15 acts with the GRB2 ortholog SEM-5 to promote chemoattraction and migration by the sex myoblasts (SMs) and fluid homeostasis by the hypodermis (Hyp7). Cell-specific differences in EGL-15 signaling were suggested by the phenotypes caused by egl-15(n1457), an allele that removes a region of its C-terminal domain (CTD) known to bind SEM-5. To determine how mutations altered EGL-15 activity in the SMs and Hyp7, we used the kinase reporter ERK-KTR to measure activation of the ERK ortholog MPK-1. Consequences of egl-15(n1457) were cell-specific, resulting in loss of MPK-1 activity in the SMs and elevated activity in Hyp7. Previous studies of Hyp7 showed that loss of the CLR-1 phosphatase causes a fluid homeostasis defect termed "Clear" that is suppressed by reduction of EGL-15 signaling, a phenotype termed "Suppressor of Clear" (Soc). To identify mechanisms that permit EGL-15 signaling in Hyp7, we conducted a genetic screen for Soc mutants in the clr-1; egl-15(n1457) genotype. We report the identification of SOC-3, a protein with putative SEM-5-binding motifs and PH and PTB domains similar to DOK and IRS proteins. In combination with the egl-15(n1457) mutation, loss of either soc-3, the GAB1 ortholog soc-1, or the SHP2 ortholog ptp-2, reduced MPK-1 activation. We generated alleles of soc-3 to test the requirement for the SEM-5-binding motifs, finding that residue Tyr

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsReceptors, Fibroblast Growth FactorSignal TransductionAnimalsMitogen-Activated Protein Kinase 1MutationCaenorhabditis elegans ProteinsEGL-15 protein, C elegansMitogen-Activated Protein Kinase 1mpk-1 protein, C elegansReceptors, Fibroblast Growth FactorCell signalingDownstream of kinaseExtracellular signal-regulated kinaseFibroblast growth factorInsulin receptor substrateReceptor tyrosine kinase

Identifiers

PMID39173814
PMCPMC11488645

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.